Prognostic Factors for Glioblastoma Multiforme: Development of a prognostic index

References

• Lote K., Gundersen S., Hannisdal E. Prognosen ved primsre svulster i sentralnervesystemet. Det Norske Radi-umhospitals pasientmateriale 1980–1994. Tidsskr Nor Lege-foren 1996; 11: 1320–4
   Google Scholar
• Kelly K. A., Kirkwood J. M., Kapp D. S. Glioblastoma multiforme: pathology natural history and treatment. Cancer Treat Rev 1984; 11: 1–26
   PubMed Web of Science ®Google Scholar
• Anderson A. P. Postoperative irradiation of glioblastomas. Results in a randomised series. Acta Radiol 1978; 17: 475–84
   Google Scholar
• Kristiansen K., Hagen S., Kollevold T. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of post-operative irradiation and lack of potentiation of bleomycin on survival time. Cancer 1981; 47: 649–52
   PubMed Web of Science ®Google Scholar
• Walker M. D., Alexander E., Hunt W. E. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 1978; 49: 333–43
   PubMed Web of Science ®Google Scholar
• Walker M. D., Green S. B., Byar D. P. Randomised comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Eng J Med 1980; 303: 1323–9
   PubMed Web of Science ®Google Scholar
• Green S. B., Byar D. P., Walker M. D. Comparison of carmustine procarbazine and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 1983; 67: 121–32
   PubMedGoogle Scholar
• Fine H. A., Dear K. G. B., Loeffler J. S. Meta-analysis of radiation therapy with and without chemotherapy in malignant gliomas in adults. Cancer 1993; 71: 2585–97
   PubMed Web of Science ®Google Scholar
• Bloom H. J. G. Intracranial tumours: Response and resistance to therapeutic endeavours 1970–1980. Int J Radiat Oncol Biol Phys 1982; 8: 1083–113
   PubMed Web of Science ®Google Scholar
• Gaspar L. E., Fisher B. J., Macdonald D. R. Malignant glioma-Timing of response to radiation therapy. Int J Radiat Oncol Biol Phys 1993; 25: 877–9
   PubMedGoogle Scholar
• Leibel S. A., Sheline G. E. Radiation therapy for brain tumors. J Neurosurg 1987; 66: 1–21
   PubMed Web of Science ®Google Scholar
• Levin S. A., Sheline G. A., Gutin P. H. Cancer of the central nervous system. Cancer. Principles and practice of oncology, V. T. DeVita. JB Lippincott, Philadelphia 1989; 79–1557
   Google Scholar
• Loeffler J. S. Radiotherapy in managing malignant gliomas: Current role and future directions. Adv Oncol 1992; 8: 14–20
   Google Scholar
• Nelson D. F., Diener-West M., Horton J. Combined modality approach to treatment of malignant gliomas-Reeval-uation of RTOG 7401/ECOG 1374 with long-term follow up: A joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. NCI Mono 1988; 6: 279–84
   Google Scholar
• Bauman G. S., Gaspar L. E., Fisher B. J. A prospective study of short course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1994; 4: 835–9
   Google Scholar
• Hutton J. L., Smith D. F., Sandemann D. Development of a prognostic index for primary supratentorial intracerebral tumours. J Neurol Neurosurg Psychiat 1992; 55: 271–4
   PubMed Web of Science ®Google Scholar
• A report of the Medical Research Council Brain Tumour Working Party. Prognostic factors for high-grade malignant glioma: Development of a prognostic index. J Neuro-Oncol 1990; 9: 47–55
   PubMedGoogle Scholar
• International histologic classification of tumours No. Histologic typing of tumours of the central nervous system. WHO, Geneva 1979; 21
   Google Scholar
• Peto R., Pike MC, Armitage P. Design and analysis of clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Dixon W. J., Brown M. B., Engelman L. ‘BMDP Statistical Software 1983’. University of California Press, Berkeley 1983
   Google Scholar
• Watne K., Hannisdal E., Nome O. Prognostic factors in high-grade malignant gliomas with reference to intra-arterial chemotherapy. Acta Oncol 1993; 32: 307–10
   PubMed Web of Science ®Google Scholar
• Gehan E. A., Walker M. D. Prognostic factors for patients with brain tumors. NCI Mono 1977; 46: 189–95
   Google Scholar
• Byar D. P., Green S. B., Strike T. A. Prognostic factors for malignant glioma. Oncology of the nervous system, M. D. Walker. Martinus Nijhoff, Boston 1983; 95–379
   Google Scholar
• Brisman R., Housepian E. M., Chang C. Adjuvant nitrosourea therapy for glioblastoma. Arch Neurol 1976; 33: 745–50
   PubMedGoogle Scholar
• Eyre H. J., Quagliana J. M., Eltringham J. R. Randomized comparisons of radiotherapy and CCNU versus radiotherapy CCNU plus procarbazine for the treatment of malignant gliomas following surgery. J Neuro-Oncol 1983; 1: 171–7
   PubMed Web of Science ®Google Scholar
• Chang C. H., Horton J., Schoenfeld D. Comparison of post-operative radiotherapy and combined post-operative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 1983; 52: 997–1007
   PubMed Web of Science ®Google Scholar
• Smith D. F., Hutton J. L., Sandemann D. The prognosis of primary incerebral tumours presenting with epilepsy: the outcome of medical and surgical management. J Neurol Neuro-surg Psychiatry 1991; 54: 915–20
   PubMed Web of Science ®Google Scholar